Anticoagulant activities of oleanolic acid via inhibition of tissue factor expressions
2
조회
0
다운로드
11
인용
0
참고문헌
키워드
초록
Oleanolic acid (OA), a triterpenoid known for its anti-inflammatory and anti-cancer properties, is commonly present in several medicinal plants but its anticoagulant activities have not been studied. Here, the anticoagulant properties of OA were determined by monitoring activated partial thromboplastin time (aPTT),prothrombin time (PT), fibrin polymerization as well as cell-based thrombin and activated factor X (FXa) generation activities. Data showed OA prolonged aPTT and PT significantly and inhibited thrombin catalyzed fibrin polymerization. In addition, OA inhibited the activities of thrombin and FXa and inhibited the generation of thrombin or FXa in human endothelial cells. OA also inhibited TNF-α-induced tissue factor expression on human endothelial cells. In accordance with these anticoagulant activities, OA showed an anticoagulant effect in vivo. These results indicate that OA possesses antithrombotic activities and suggest that daily consumption of a herb containing OA may be preventing thrombosis in pathological states. [BMB Reports 2012; 45(7): 390-395]
Abstract
Oleanolic acid (OA), a triterpenoid known for its anti-inflammatory and anti-cancer properties, is commonly present in several medicinal plants but its anticoagulant activities have not been studied. Here, the anticoagulant properties of OA were determined by monitoring activated partial thromboplastin time (aPTT),prothrombin time (PT), fibrin polymerization as well as cell-based thrombin and activated factor X (FXa) generation activities. Data showed OA prolonged aPTT and PT significantly and inhibited thrombin catalyzed fibrin polymerization. In addition, OA inhibited the activities of thrombin and FXa and inhibited the generation of thrombin or FXa in human endothelial cells. OA also inhibited TNF-α-induced tissue factor expression on human endothelial cells. In accordance with these anticoagulant activities, OA showed an anticoagulant effect in vivo. These results indicate that OA possesses antithrombotic activities and suggest that daily consumption of a herb containing OA may be preventing thrombosis in pathological states. [BMB Reports 2012; 45(7): 390-395]
참고문헌 (24)
- Kaiser, L., "Endothelial cells. Not just a cellophane wrapper", Arch. Intern. Med., 147, pp.569~573 (1987)
- Davie, E. W., "Biochemical and molecular aspects of the coagulation cascade", Thromb. Haemost., 74, pp.1~6 (1995)
- Chong, A. Y., "Assessment of endothelial damage and dysfunction: observations in relation to heart failure", QJM, 96, pp.253~267 (2003)
- Davie, E. W., "The coagulation cascade: initiation, maintenance, and regulation", Biochemistry, 30, pp.10363~10370 (1991)
- Monroe, D. M., "Platelets and thrombin generation", Arterioscler. Thromb. Vasc. Biol., 22, pp.1381~1389 (2002)
- Quinn, C., "A guide for diagnosis of patients with arterial and venous thrombosis", Clin. Lab. Sci., 13, pp.229~238 (2000)
- Della Valle, P., "Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid- antibody syndrome", Haematologica, 84, pp.1065~1074 (1999)
- Furie, B., "Thrombus formation in vivo", J. Clin. Invest., 115, pp.3355~3362 (2005)
- Li, S. S., "Mistletoe lectins: telomerase inhibitors in alternative cancer therapy", Drug. Discov. Today, 7, pp.896~897 (2002)
- Kim, B. K., "Protective Effects of Korean Mistletoe Lectin on Radical-Induced Oxidative Stress", BIOLOGICAL & PHARMACEUTICAL BULLETIN, 33, pp.1152~1158 (2010), PHARMACEUTICAL SOC JAPAN
- Yoon, T. J., "Lectins isolated from Korean mistletoe (Viscum album coloratum) induce apoptosis in tumor cells", Cancer Lett., 136, pp.33~40 (1999)
- 강태봉, "Cellular and humoral adjuvant activity of lectins isolated from Korean mistletoe (Viscum album colaratum)", INTERNATIONAL IMMUNOPHARMACOLOGY, 1, pp.881~889 (2001), ELSEVIER SCIENCE BV
- Yoon, T. J., "Antitumor activity of the Korean mistletoe lectin is attributed to activation of macrophages and NK cells", ARCHIVES OF PHARMACAL RESEARCH, 26, pp.861~867 (2003), PHARMACEUTICAL SOC KOREA
- Bae, J. S., "Antithrombotic and profibrinolytic activities of phloroglucinol", Food Chem. Toxicol., 49, pp.1572~1577 (2011)
- Liu, J., "Oleanolic acid and ursolic acid: research perspectives", J. Ethnopharmacol., 100, pp.92~94 (2005)
- Dzubak, P., "Pharmacological activities of natural triterpenoids and their therapeutic implications", Nat. Prod. Rep., 23, pp.394~411 (2006)
- Sugo, T., "Activation of prothrombin by factor Xa bound tothe membrane surface of human umbilical vein endothelialcells: its catalytic efficiency is similar to that of prothrombinasecomplex on platelets", J. Biochem., 117, pp.244~250 (1995)
- Rao, L. V., "Enhancement by human umbilical vein endothelial cells of factor Xa-catalyzed activation of factor VII", Blood, 71, pp.791~796 (1988)
- Ghosh, S., "Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surface", J. Thromb. Haemost., 5, pp.336~346 (2007)
- Fischer, K. G., "Essentials of anticoagulation in hemodialysis", Hemodial. Int., 11, pp.178~189 (2007)
- Cho, S. O., "Aralia cordata Protects Against Amyloid beta Protein (25-35)-Induced Neurotoxicity in Cultured Neurons and Has Antidementia Activities in Mice", JOURNAL OF PHARMACOLOGICAL SCIENCES, 111, pp.22~32 (2009), JAPANESE PHARMACOLOGICAL SOC
- Nowak, P., "Different vulnerability of fibrinogen subunits to oxidative", nitrative modifications induced by peroxynitrite: functional consequences, 2007, pp.121, 163~174
- Bae, J. S., "Protease activated receptor1 (PAR-1) activation by thrombin is protective inhuman pulmonary artery endothelial cells if endothelialprotein C receptor is occupied by its natural ligand", Thromb. Haemost., 100, pp.101~109 (2008)
- Dejana, E., "Bleeding time in laboratory animals. II - A comparisonof different assay conditions in rats", Thromb. Res., 15, pp.191~197 (1979)